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1. Introduction  
Cervical and lumbar disc arthroplasty are one component in the continuum of treatment for 
symptomatic degenerative disc disease (DDD) that is unresponsive to conservative care. In 
the lumbar spine, this may be accomplished via nucleus replacement or total disc 
replacement, and in the cervical spine by total disc replacement. The goal of both lumbar 
disc arthroplasty treatments are the same; relieving discogenic back pain through removing 
the pain source and restoring or maintaining motion segment function. For cervical 
arthroplasty, the goal is to relieve radicular pain as a result of nerve root compression, 
and/or myelopathy as a result of spinal cord compression, in addition to preserving motion. 
From a design standpoint, nucleus replacement technology consists of elastomers and non-
elastomers, both preformed and in-situ cured, and can incorporate articulation similar to 
total disc replacements, with the intent of replicating to various extents the natural nucleus 
and preserving most of the annulus, thereby relying on a biomechanically intact annulus to 
share the compressive load. Also, most artificial nucleus devices are not fixed to the 
vertebral endplates, and therefore allow small, relative motion between their external 
surfaces and the vertebral endplates. In contrast, the majority of total disc replacement 
technology consists of articulating designs and material combinations that have been 
developed based upon the wealth of scientific and clinical information produced by the 
success of total joint arthroplasty. An artificial disc is designed to replace the entire disc 
tissue by excising almost all the disc materials, and therefore removing all the natural 
constraints in the anterior column. In addition, all artificial discs have a superior plate and 
an inferior plate, which are fixed to the two adjacent vertebrae. These represent key design 
differences between the two technologies.  
A key challenge for a disc arthroplasty device is selecting the proper material(s) for the 
various components that consitute its design. Unlike total joint replacement, a candidate for 
disc arthroplasty is on average 40 years of age with a target indication of 18 to 60 years 
(Zigler et al., 2007; Murrey et al., 2009). As a consequence, these devices are expected to last 
much longer than those of total joint recipients, whose average age is 70 years (Bergen, 2011, 
Garellick et al., 2010). Therefore, there are stringent requirements for long term implantable 
materials, and this will significantly limit the selection of materials available. 
Biocompatibility and biodurability, otherwise known as the abilities of a material to 
maintain its physical and chemcial integrity under in vivo applications without eliciting an 
aggressive host immune response for a given application, are essential for permanent 
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medical implants. Since a central tenet of all arthroplasty devices is the preservation of 
motion, it is therefore expected that these devices will produce wear particulate, and the 
subsequent potential biologic activity needs to be evaluated. This is in addition to exhibiting 
sufficient strength and fatigue performance over the expected lifetime of the device within 
the in vivo environment. Subsequently, disc arthroplasty devices should be introduced into 
clinical use only after a successful preclinical evaluation of their mechanical and biological 
properties within the scope of their intended use, as failure can lead to a technically 
challenging revision, increased economic burden and more importantly, a significant risk to 
the patient (Devin et al., 2008, Cavanaugh et al., 2009, Francois et al., 2007, Guyer et al. 2011, 
Lucina & Thorpe, 2004, Punt et al., 2009).  
Initially, much of the preclinical testing of candidate materials is not conducted on the 
device but rather the material itself. Logical progression then leads to testing of the device 
itself, since the design of the device will also affect a given materials performance. These 
tests should include bench top testing such as static and fatigue assessments, wear testing, 
and evaluation in human cadaver and animal models. The wear, mechanical durability and 
potential resultant biologic activity of disc arthroplasty devices are a key component that 
needs to be addressed prior to clinical use. This can be assessed to a large extent by the 
appropriate wear tests for articulating devices and fatigue tests in the case of devices that 
utilize elastomers for the basis of their motion. However, in the absence of significant 
implant retrievals, the appropriate tests to perform in assessing a respective devices’ 
durability properties becomes critical. Device fatigue and wear may decrease the devices’ 
lifespan for its intended application. In addition, the wear particulate generated may result 
in a particle mediated inflammatory response potentially leading to osteolysis or delayed 
type hypersensitivity. Evaluation of the particulate generated can allow for assessment of 
potential biologic reactivity. Successful animal models can act as a final spring board for 
initiation of clinical studies by evaluation of the mechanical behavior and elicited 
histopathological response of the device component materials following long-term 
implantation. Analyses can based upon gross necropsy, MRI radiography, plain X-ray, 
microradiography, multi-directional flexibility testing and biocompatibility assays (local and 
systemic histology). The overall successful completion and evaluation of these studies 
allows for advancement to the clinical stage.  
Traditionally metal alloys, ceramics and polymers have been the materials of choice for 
arthroplasty applications. Ceramics are noted for their high wear resistance and strength, 
and metal alloys, such as titanium (Ti) and cobalt chrome (CoCr) for their high strength, 
fracture toughness and hardness; properties that are necessary for long term implantable 
materials. Polymers are a more compliant material, with low-friction properties ideal for 
articulating surfaces which produce relatively inert wear debris. These materials and 
combinations thereof have a long clinical history in total joint arthroplasty. Therefore, 
material combinations such as metal on UHMWPE and metal on metal are typically used for 
articulating disc replacements based upon the established scientific and clinical history of 
these bearing couples in total joint arthroplasty. Poly-ether-ether-ketone (PEEK) is a linear, 
aromatic thermoplastic with proven biocompatibility and biostability. It can be repeatedly 
steam and gamma sterilized with no detrimental effects on its bulk material properties. It is 
an exceptionally strong engineering thermoplastic that retains its mechanical properties 
even at very high temperatures (Rae, 2007). The material is tough and abrasion resistant 
with high-impact strength and excellent flexural and tensile properties. It has a low 
coefficient of friction and resists attack by a wide range of organic and inorganic chemicals 
and solvents. To this end, PEEK  is widely used in the lumbar spine for both fusion 
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(Rousseau et al., 2007) and non-fusion applications (Balsano, 2011;  Senegas, 2002) due to its 
excellent mechanical strength, biostability, biocompatibility and radiolucency (Kurtz & 
Devine, 2007), and has replaced to a significant extent the use of metallic cages. It is also 
commonly used in the cervical spine in the form of interbody cages for fusion. Therefore, it 
potentially has most of the material characteristics deemed to be required for use as material 
in spine arthroplasty applications. However, unlike traditional polymers and metals, 
common materials used in the spine arthroplasty arena, the use of PEEK represents a new 
material for disc arthroplasty applications in the cervical and lumbar spine, and as such, its 
use as a material for this technology has largely gone unexplored. 
PEEK has recently been used in the form of a nucleus replacment device and in the form of a 
cervical total disc replacement. Both devices utilize a ball and socket articulation for motion. 
As part of evaluating the safety and effectiveness profile of both devices, several preclinical 
tests were successfully performed to satisfy FDA and the Essential Requirements of the 
Medical Device Directive (MDD) for CE mark requirements prior to clinical use. Each device 
is CE marked and currently in clinical use. Worldwide clinical results as measured by 
validated measures such as Oswestry Disability Index (ODI), Visual Analog Scale (VAS), 
along with patient satisfaction, suggest that both devices can relieve the symptoms of their 
respective degenerative processes, with no adverse events occurring as a direct result of the 
device not performing as expected from a biomaterial perspective. The methodology, results 
and interpretation of these preclinical studies that have allowed for advancement to the 
clinical stage will be discussed, along with the clinical results in light of both devices’ clinical 
performance. 
2. Preclinical studies and results 
2.1 PEEK cervical total disc replacement device 
The cervical arthroplasty device incorporates a unique, Ti cam blade fixation system that can 
be described as a rotating shaft with blades for primary fixation (Figure 1). Given that PEEK 
is a relatively bio-inert material, bone apposition does not readily occur onto the material. 
Therefore, a plasma-sprayed hydroxyapatite (HA) coating was added to the outer endplates. 
The design objectives are to achieve secure, long term fixation within the disc space, exhibit 
the necessary strength and durability for the lifetime of the patient for its intended use, and 
restore or maintain the range of motion (ROM) at the operative level while simultaneously 
not adversely affect the biomechanics at the adjacent levels. 
 
 
Fig. 1. PEEK cervical arthroplasty device. 
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2.1.1 Axial static and fatigue strength 
To determine the static and fatigue strength of the device, the smallest footprint (12x14 mm) 
and height (5 mm) was utilized. Testing was performed on an MTS 858 Mini-Bionix II test 
frame with the devices mounted on steel fixtures. A comparison was made between HA 
coated devices and uncoated devices to determine if the coating had an adverse effect on the 
static and fatigue strength of the device. A sample size of 6 was used for the static test with a 
displacement rate of 2 mm/min. The acceptance criteria was an offset yield load of greater 
than 1200 N for the axial static testing. For the fatigue tests, a sample size of 2 was used with 
a starting fatigue load of 75% of the static offset yield load of the uncoated devices, with 
R=10 at 10 Hz.  
For the axial static testing, the results showed that the mean load at offset yield was 
calculated to be 7,631 ± 171 N at a displacement of 0.50 ± 0.01 mm for the uncoated devices 
and 9640 ± 251 N at a displacement of 0.70 ± 0.02 mm for the coated devices, which was 
significantly greater (t-test, p<0.001). The primary mode of failure in the tested constructs 
was fracture of the PEEK. For the axial fatigue testing, the uncoated and coated samples 
reached 10 million cycles at a load of 5723 N (R=10). No evidence of failure, such as fatigue 
cracks or gross deformation, was seen during the inspections or after test. When the coated 
devices were tested at a load of 7230 N, implant fracture occurred at 867,966 cycles. 
The literature suggests that the maximum compressive load on the cervical spine during the 
performance of physical tasks is 1.2 kN [Moroney, 1988] and that the elastic limit of single 
motion segments could be as high as 1.23 kN, with a predicted ultimate compressive 
strength of 2.40 kN [Przybyla, 2007]. The results showed that the loads reached were 
significantly above the expected in vivo loads of the cervical spine, and that the HA coating 
did not negatively affect the axial compressive static or fatigue performance.  
2.1.2 Shear static and fatigue strength 
To determine the shear static and fatigue strength of the device, the smallest footprint (12x14 
mm) and height (5 mm) was utilized. Testing was performed on an MTS 858 Mini-Bionix II 
test frame with the devices mounted on steel fixtures. According to the literature, the total 
ROM for flexion/extension of the cervical spine is greatest at the C4-C5 level, and appears to 
be slightly more than 20° when measured in vivo using computer assisted tracking software 
[Reitman, 2004]. The literature also shows that the amount of mean flexion is only slightly 
higher than the mean extension [Panjabi, 2001]. Therefore, the shear test was conducted at 
10° for both flexion and extension. A comparison was made between HA coated devices and 
uncoated devices to determine if the coating had an adverse effect on the shear static and 
fatigue strength of the device. A sample size of 6 was used for the static tests with a 
displacement rate of 2 mm/min. The acceptance criteria was an offset yield load of greater 
than 135 N [Moroney, 1988] for the shear static testing and for the fatigue tests, a sample size 
of 2 was used with a run out load greater than 135 N [Moroney, 1988] with R=10 at 10 Hz. 
For the shear static testing at 10° flexion, the mean load at offset yield was calculated to be 
4774 ± 372 N at a displacement of 0.44 ± 0.01 mm. For the shear static testing at 10° extension 
static shear, the mean load at offset yield was calculated to be 6788 ± 412 N at a 
displacement of 0.53 ± 0.02 mm. The primary mode of failure was fracture of the PEEK 
(Figure 2). Since the results of the static compressive shear strength resulted in a lower offset 
yield load in flexion (4744 N) versus extension (6788 N), the fatigue test was run at 10° 
flexion as a worst case scenario. The results of the fatigue testing at 1600 N showed the 
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devices reached 10 million cycles without experiencing any visible plastic deformation or 
fracture. For the coated devices, since the shear static loading was significantly higher than 
the acceptance criteria and the coating was shown to not have a detrimental effect on the 
axial static properties of the device, only shear fatigue testing was performed. The results 
were the same as the coated devices, 1600 N of compressive shear to 10 million cycles 
without experiencing any visible plastic deformation or fracture. Therefore, it was 
concluded that shear fatigue loads can be withstood far beyond those that would be 
expected in vivo. 
 
 
Fig. 2. PEEK cervical arthroplasty device after static compressive shear testing to failure.  
Left – tested under 10° flexion, right – tested under 10° extension.  
2.1.3 Fixation strength 
The fixation strength of the device was assessed by determining its pull out strength using a 
synthetic vertebral model. The largest (17x17 mm) and smallest footprints (12x14 mm) of 8 
mm height were utilized. To avoid the variability produced by human cadaveric tissue, 
including bone mineral density and endplate geometries, a synthetic fixation medium of 
ASTM grade 15 polyurethane foam was selected for use. The fixation pull out test model 
consisted of compressing the device between two polyurethane blocks to 60 lbs, and then 
performing a uniaxial tensile load to failure test, thereby forcibly removing the implant. The 
test was conducted on an MTS 858 Mini-Bionix II test frame with appropriate fixturing. The 
displacement rate was 2.5 mm/sec. The implant was placed between the blocks in 
accordance with the surgical technique. A minimum of ten pullout tests were performed for 
each implant size. This data was then compared to eight previously tested cervical disc 
arthroplasty devices used clinically in cervical reconstruction that utilize press fit, keel or 
screw fixation using the same test protocol and laboratory [Cunningham, 2010]. Therefore, 
the results of this testing provides for a standardized testing methodology to quantify the 
strength of fixation and resistance to migration.  
In all pullout tests for the two implant sizes, there was no incidence of intrinsic device 
failure. Failure always occurred at the polyurethane block-implant interface. The cam blade 
fixation indicated the highest pullout strength, which was statistically different from nearly 
all other designs (Table 1). Prosthetic endplates containing toothed ridges and keel fixation 
ranked next in terms of fixation strength. Although intuition favored the coronal keel as 
affording an increased mechanical advantage over the toothed surface, there were no 
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observed statistical differences in pullout strength between the two endplate designs 
(p>0.05). In fact, the toothed surfaces indicated a slightly higher failure load over the keel 
device, although not statistically different. Moreover, the utilization of toothed ridges  
 
Experimental Group Device Fixation 
Type 
Endplate Surface 
Area (mm2) 
Failure Load 
(N) 
PEEK cervical device 
(small) 
 
Cam blade 168 386.3 ± 44.1* 
PEEK cervical device 
(large) 
 
Cam blade 289 566.2 ± 72.0** 
PCM Low Profile 
 
0.2 mm endplate 
serrations 
  
300 257.4 ±28.5 
PCM V-Teeth 
 
0.2 mm endplate 
serrations with 1.0 
mm toothed ridges 
  
300 308.8 ± 15.3 
PCM Modular Flange 
 
Serration with (4) 4 
mm x 15 mm screws 
 
300 496.4 ± 40.0 
PMC Fixed Flange 
 
(4) 4 mm x 15 mm 
screws 
 
300 528.0 ± 127.8 
Prestige LP 
 
2.3 mm height 
center keel with 
teeth 
275 306.4 ± 31.3 
Kineflex C 
 
0.2 mm endplate 
serrations with 2.5 
mm height center 
keel 
 
250 286.9 ± 18.4 
Anterior Cervical Plate 
with Interbody Cage 
 
Serration with 4 
screws 
180 635.5 ± 112.6 
Iliac Crest Autograft N/A 235 161.6 ± 16.6 
Table 1. Fixation strength of the PEEK cervical arthroplasty device as compared to other 
forms of fixation. * Fixation strength was significantly greater than all others with the 
exception of PCM Fixed Flange and Anterior Cervical Plate with Interbody Cage. **Fixation 
strength was significantly greater than all others with the exception of PCM Fixed and 
Modular Flange, Prestige LP and Anterior Cervical Plate with Interbody Cage. There were 
no statistical differences between endplate surface areas. 
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elevated beyond 1.0mm did not significantly improve fixation strength (p>0.05). Prosthetic 
endplates containing serrated edges (0.2mm) alone indicated the lowest fixation strength. 
These results indicate not only a high fixation strength but the ability of the PEEK housing 
for the cam blades to withstand the expected in vivo shear forces placed upon the device. 
2.1.4 Wear testing and wear particulate characterization 
Wear testing was performed on six devices of the smallest footprint (12x14 mm) and 5 mm 
height using an MTS Spine Wear Simulator. The test parameters consisted of ASTM 
F2423-05 recommended multidirectional motion and static load profiles from 0-10 million 
cycles followed by ISO 18192-1 recommended motion and dynamic load profiles from 10-
20 million cycles. The test frequency was 2 Hz for motion and 4 Hz for load. The testing 
fluid consisted of newborn calf serum diluted with phosphate buffered saline (PBS) to a 
final protein content of 20 g/L. Ethylene-diamine tetraacetic acid (EDTA) was added to 
the serum at a concentration of 20 mM to bind the calcium ions present in the serum. 
EDTA is a known preservative, and together with the low protein content and PBS, the 
addition of sodium azide or other anti-bacterial agent was not used. The test fluid 
temperature was kept at 37 ± 3° C. Unloaded soak controls were used to account for 
moisture uptake. After 0.5 million cycles, the tests were stopped at 1 million cycles and at 
million-cycle intervals thereafter to clean, dry and gravimetrically assess the wear rates. 
The test fluid was subsequently collected and stored at -20° C. The average wear rates 
were determined using linear regression analysis with one-way-analysis-of-variance 
(ANOVA) used to determine if significant differences (p < 0.05) in the wear rates between 
methodologies were present. Complimentary to the wear testing, particle analysis was 
performed using light scanning electron microscopy (SEM). The proteinacious test serum 
containing PEEK wear debris underwent enzymatic digestion (5x Trypsin digestion and 
1.5 mg/mL of Proteinase K per sample at 37° C for 24 hours) followed by a mild acid 
treatment (10% HCl at 37° C for 24 hours), meeting or exceeding similar protocols 
previously established to be equivalent for acid and base digestion (Niedzwiecki, 2001). 
The particles were then analyzed by SEM analysis and characterized according to their 
equivalent circle diameter (ECD), aspect ration (AR), roundness (R) and form factor (FF) 
in accordance with ASTM F 1877-05. 
All implants maintained full functionality throughout each test duration. The results 
showed only a slight, non-significant variation in the wear rates over the course of 20 
million cycles. The wear rate for the first 10 million cycles was approximately 0.26 ± 0.01 
mm3/million cycles. For the interval of 10 to 20 million cycles, the wear rate increased 
slightly, 0.32 ± 0.02 mm3/million cycles. These wear rates are similar to other arthroplasty 
devices in clinical use (Figure 3). Although the wear rates were relatively consistent, the 
particle size was sensitive to the test method. The particle analysis revealed that the size 
(ECD) of the particulate was larger for the ISO testing methodology (2.56 µm) as compared 
to the ASTM methodology (1.67µm) (Figure 4). However the particle morphology, an 
equally important parameter influencing biological activity, was similar for both methods. 
The ASTM testing revealed a smaller particulate; however it may be unlikely that a static 
compressive load occurs in the cervical spine in vivo, since the literature suggests that a 
dynamic compressive load occurs due to muscle contraction during kinematic activities 
[Snijders, 1991].  
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Fig. 3. Wear rate comparison of the PEEK cervical arthroplasty device to other devices in 
clinical use. 
 
 
Fig. 4. SEM analysis of the PEEK particulate generated from the wear tests. 
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Methodology Group 1- Normal Load Group 2 - Artificially Aged Group 3 – High Load 
 
Environmental 
Condition 
Sterilization 
Aging 
 
 
 
30 kGy in air 
N/A 
 
 
 
200 kGy in air 
Exposure to O2 at 70° C 
for 40 days 
 
 
 
30 kGy in air 
N/A 
 
Dynamic 
Compressive  
Load 
 
 
225…1024 N 
 
 
225…1024 N 
 
 
200…2000 N 
 
Motion 
 
ISO - 6°/3° 
flexion/extension 
±2° lateral bending and 
axial rotation to 10 
million cycles 
 
ISO - 6°/3° 
flexion/extension 
±2° lateral bending and  
axial rotation to 10 
million cycles 
 
 
ISO - 6°/3° 
flexion/extension 
±2° lateral bending and  
axial rotation to 10 
million cycles 
Test Frequency Compressive Load   4 Hz 
Motion                          2 Hz 
Compressive Load    4 Hz 
Motion                           2 Hz 
Compressive Load   4 Hz  
Motion                          2 Hz  
Table 2. Summary of Testing Methodology for All Groups. 
2.1.5 Hydroxyapatite coating and substrate effects 
The HA coating is applied to the outer endplates of the device via the well known plasma 
spray process. The coating was characterized in accordance with FDA guidelines. Given that 
the device’ material (PEEK) is being exposed to what is considered a high temperature process, 
a potential change in the materials biocompatibility profile and/or material properties could 
occur. Therefore, several tests were performed to ensure that the thermal and chemical 
signature of the PEEK substrate was not adversely affected. This consisted of Differential 
Scanning Calorimetry (DSC), Thermal Gravimetric Analysis (TGA) and Fourier Transform 
Infrared Spectroscopy (FTIR), the most common tools used to characterize polymers. This was 
then compared with the 20-year historical measurements of PEEK provided by the 
manufacturer (Invibio). Analyses were performed on bulk and surface samples.  
For the DSC, TGA and FTIR analysis, six machined samples of HA coated PEEK that 
subsequently had the coating removed by a 10% phosphoric acid treatment were compared 
to machined PEEK samples that had not been coated. The DSC analysis showed similarity 
between all samples and to machined PEEK samples. Likewise, ATR-FTIR showed no 
appreciable difference in the tested samples. TGA analysis resulted in primary degradation 
of the samples starting at approximately 550ºC and continuing until about 625ºC, showing 
an initial degradation loss of 35%. There was a dramatic decrease in sample mass (65% of 
the initial mass down to 0% of the initial mass) of the samples between 625º C and 800º C. 
There was no appreciable difference in the samples, and the degradation response looked 
very similar to the machined PEEK samples. All observed values (mean, maximum and 
minimums) were within the 20 year historical ranges of PEEK as verified by Invibio. More 
importantly, from a biocompatibility standpoint, since there were no additional absorption 
peaks found in the regions that formerly had an HA coating, and the HA coating was 
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readily removed with a mild solvent, it is highly unlikely that any covalent bonding 
occurred between the HA and the PEEK material. Furthermore, there was no measurable 
change in the molecular structure of the PEEK induced by adding the HA layer. Therefore, 
no chemical bonding was noted to occur, the surface properties and subsequently the 
biocompatibility profile of the PEEK substrate have not changed, and it can be concluded 
that only a mechanical bond exists between the PEEK and HA coating.  
Biocompatibility tests in accordance with ISO 10993 parts 5, 10 and 11 were conducted at 
NAMSA. These tests were carried out on coated and an equal number of substrates having 
the coating removed with a mild solvent (phosphoric acid) in order to expose the 
underlying substrate. The control consisted of virgin PEEK:   
ISO 10993,  Part 5: Tests for Cytotoxicity- 
HA coated PEEK and coated PEEK that had the coating removed, were prepared using 
single strength Miminum Essential Medium supplemented with 5% serum and 2% 
antibiotics (1X MEM). The test extracts were placed onto three separate monolayers of L-929 
mouse fibroblast cells propagated in 5% CO2. Three separate monolayers were prepared for 
the reagent control, negative control and for the posititve control. All monolayers were 
incubated at 37° C in the presence of 5% CO2 for 48 hours at which point they were 
examined microscopically to determine any change in cell morphology. Under the 
conditions of this study, the 1X MEM test extract showed no evidence of causing cell lysis or 
toxicity. The reagent control, negative control and the positive control performed as 
anticitpated. Therefore the requirements of the study were met. 
ISO 10993, Part 10: Test for Irritation and Delayed-Type Hypersensititivity- 
A guinea  pig (Hartley albino) maximization test was conducted to evaluate the potential 
for delayed dermal contact sensitization. HA coated PEEK and coated PEEK that had the 
coating removed, were extracted in 0.9% sodium chloride USP solution (SC) and sesame 
oil, NF (SO). Each extract was intradermally injected and occlusively patched to ten test 
guinea pigs per extract in an attempt to incude sensitization. Five additional guinea pigs 
served as a control. All sites were scored at 24 and 48 hours after patch removal. HA 
coated PEEK and coated PEEK that had the coating removed, were extracted in 0.9% 
sodium chloride USP solution (SC) and sesame oil, NF (SO). A 0.2 mL dose was injected 
by the intracutaneous route into five separate sites on the right side of the the back of two 
New Zealand white rabbits. Similarly, the corresponding control was injected on the left 
side of the back of each rabbit. Observations for erythema and edema were conducted at 
24, 48 and 72 hours after injection. Under the conditions of this study, there was no 
evidence of the extracts causing delayed dermal contact sensitization in the guinea pigs or 
no erythema or edema from the extracts injected intracutaneously into the rabbits. The 
requirements of the study were met. 
ISO 10993, Part 11: Tests for Systemic Toxicity- 
HA coated PEEK and coated PEEK that had the coating removed, were extracted in 0.9% 
sodium chloride USP solution and sesame oil, NF. A single dose of the extract was injected 
into five mice per extract by either the intravenous or intraperitoneal route. Five mice served 
as a control. The animals were observed immediately and at 4, 24, 48 and 72 hours after 
injection. Under the conditions of this study, there was no mortality or evidence of systemic 
toxicity from the extracts, and therefore the requirements of the study were met. 
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2.1.6 Biomechanical analysis  
Using an in-vitro human cadaveric model, the range of motion (ROM) of the device was 
evaluated at a single level, with data analysis based on the resulting operative and adjacent 
level multidirectional flexibility properties. A total of twelve fresh-frozen human cadaveric 
cervical spines (C1T3) were harvested en-bloc and utilized. Prior to biomechanical analysis, 
standard anteroposterior and lateral plain films were obtained to exclude specimens 
demonstrating intervertebral disc or osseous pathology. In preparation for biomechanical 
testing, the specimens were thawed to room temperature and cleaned of all residual 
musculature, with care taken to preserve all ligamentous attachments and facet joint 
capsules. The proximal (C1C3) and distal (T1T3) ends of the specimen were stabilized in 
metal tubing containers using four, four point compression screws. An optoelectronic 
motion measurement system (3020 Optotrak System) was used for kinematic analysis under 
a pure moment loading to evaluate the flexion/extension, lateral bending and axial 
rotational response after reconstruction of the C4C5 cervical level. A comparision was made 
between the intact, destabilized, reconstructed and fusion procedures. 
Flexion/extension testing demonstrated the diskectomy condition as producing a five 
degree increase (10.5 to 15.6°) in operative level range of motion compared to the intact 
spine and was statistically greater than intact and anterior plate-cage groups (p<0.05). 
Implantation of the PEEK cervical artificial disc restored motion to near intact level (11.9°) 
which was not statistically different from the intact spine (10.5°) (p > 0.05). The final 
reconstruction using the anterior plate-cage decreased the mean range of motion to 8.71° 
at the operative level, which resulted in significantly less range of motion than the PEEK 
artificial disc (11.9°) (p<0.05) but not intact condition (10.5 dg) (p>0.05). The elevated 
mean range of motion value for this reconstruction is attributable to the segmental 
instability created by the diskectomy condition (ANOVA F=3.72, p=0.018). Biomechanical 
testing in lateral bending loading did not reveal any significant differences in range of 
motion when comparing the intact spine and three treatment groups (p>0.05). Diskectomy 
(7.63°), PEEK artificial disc (6.90°) or anterior plate-cage construct (6.77°) afforded a 
statistical change in flexibility compared to the native intact condition (7.10°). The high 
standard deviation in the range of motion account for the lack of statistical significance 
under this loading modality (ROM: ANOVA F=0.58, p=0.633). Biomechanical testing in 
axial rotation indicated no statistical differences in ROM between the intact spine, 
diskectomy, PEEK total disc replacement or anterior plate-cage group (p>0.05). The 
cervical disc replacement procedure (7.21°) resulted in a slight increase in operative level 
flexibility relative to the intact (6.05°) and diskectomy conditions (6.44°) (p>0.05). The 
trends under this biomechanical loading mode failed to reach statistical significance 
secondary to specimen variability and high standard deviations. (ROM: ANOVA F=0.22, 
P=0.882). Despite the use of the Panjabi Hybrid testing protocol, there were very minimal 
changes in adjacent level ROM when comparing the intact spine, diskectomy condition 
and two reconstruction groups (p>0.05). The only significant change was observed at the 
adjacent level in flexion extension loading condition. The normalized-to-intact ROM at 
C6C7 level in these two reconstruction conditions was significantly higher than that was 
detected in diskectomy condition (p<0.05). Similar to the operative level ROM, the trends 
under this biomechanical loading mode failed to reach statistical significance secondary to 
specimen variability and high standard deviations. 
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The greatest differences between the intact spine and three treatment groups were detected 
during flexion/extension loading. The fundamental trend in each loading condition 
demonstrated the diskectomy condition as producing, as expected, an increase in segmental 
motion. Reconstruction using the PEEK artificial disc restored motion to near intact levels. 
The final reconstruction using the anterior plate-cage construct reduced motion at the 
operative level. These reductions in segmental motion, however, were not as low as 
expected. These findings are attributable to the instability created by the diskectomy 
condition and follow patterns similar to previous biomechanical studies using anterior plate 
and interbody cages. 
2.1.7 Pilot functional animal study  
Using an in-vivo goat model, evaluation of implant osseointegration and biocompatibility 
properties of HA coated and uncoated devices was performed. These properties were 
radiographically and histologically evaluated at three months post-operatively. Mature 
female crossbred goats served as the experimental model in this pilot study as these animals 
are gentle, easy to care for and represent excellent models for cervical spine procedures. 
There were n = 4 animals for the HA coated and uncoated groups. Following the three 
month sacrifice, the operative cervical motion segments were sagittally sectioned along the 
geometric centerline of the implanted device using a Beuhler Isomet saw. Histologic 
preparation of all samples included dehydration in 100% ethanol, staining using the 
Villanueva Osteochrome Bone Stain, undecalcified solution processing and embedding in 
polymethyl-methacrylate (PMMA). Using the EXAKT Microgrinding Device, the embedded 
specimens were cut at 250 to 300 um thick, ground and polished to 75 um. 
Microradiographs were obtained of the slide-mounted specimens using Faxitron 
radiography. The slides were placed twelve inches from the beam and exposed for two 
minutes, using a technique of 45 kVp and 3mA while in direct contact with the single 
emulsion high-resolution graphics arts film. For all animals, the soft tissue organs and 
structures were resected, sectioned and prepared by a veterinarian pathologist. The 
specimens were fixed in a 10% formalin solution, underwent routine paraffin processing 
and slide preparation. Using thin-sectioning microtomy, the paraffin embedded sections 
were cut (3-5µm in thickness), slide mounted and stained using standard Hematoxylin and 
Eosin (H&E). The spinal cord and local tissue overlying the anterior aspect of the C3-C4 
operative disc level were evaluated using routine H&E and Macrophage Staining Method 
(HAM-56). The use of this staining method highlights the presence of activated 
macrophages within the local tissues. Using plain and polarized light microscopy, 
histopathological readings of the slide-mounted tissue sections, activated macrophages, 
presence of wear debris as well as any signs of foreign body giant cells, granulomas 
inflammatory reactions, degenerative changes or autolysis could be discerned. 
All operative cervical motion segments were examined for gross evidence of infection and 
local pathologic response at the time of necropsy. There was no apparent infection in any of 
the operative C3-C4 levels or adjacent motion segments. Based on gross examination at the 
time of necropsy, the local tissues from all animals were considered unremarkable and 
without evidence of ectopic bone formation or other significant histopathologic changes. 
Histopathological interpretation of the slide-mounted undecalcified specimens indicated no 
evidence of significant pathological changes in tissues within or surrounding the specimens. 
For the HA coated group, there was good intercalation of cancellous bone with the Ti 
fixation cams and bone apposition to both endplates of the devce (Figure 5). For the  
www.intechopen.com
 
The Use of PEEK in Spine Arthroplasty 223 
 
 
 
 
Fig. 5. Left - Good bone apposition to the HA coated devices was seen. Fibrous membranes 
are around the edges of both components where there is no coating applied, but there is no 
significant fibrosis at the bone/implant interface. Right – mostly fibrous tissue surrounded 
the uncoated devices. For all devices, no significant particles of debris were evident. 
uncoated group, only focal bone ingrowth to the Ti cam’s was noted, with no bone 
apposition to the PEEK, consistent with the relatively inertness of the material not 
allowing for bone apposition. For all groups, plain and polarized light microscopy of local 
tissues overlying the operative sites from experimental levels of both groups indicated a 
mild inflammatory reaction. The histiocytic infiltration responses were considered 
secondary to the surgical procedure and healing response. The spinal cord sections 
exhibited no significant pathological changes based on plain and polarized review. There 
was no evidence of giant cell reaction or other significant pathological changes, no debris 
associated with the device, aggresive inflammatory reactions, degenerative changes or 
autolysis noted. 
2.2 PEEK nucleus replacement device 
The PEEK nucleus replacement device is a two-piece implant comprised of a top and a 
bottom plate, with an inner ball and socket articulation (Figure 6). Since PEEK is 
radiolucent, tantalum (Ta) markers are used to facilitate the visualization of the device 
location when using radiographic methods. The articulation allows for rotational motions 
along all three major axes. The motion of the device in axial rotation is unconstrained, while 
the motions in flexion/extension and lateral bending are semi-constrained slightly beyond 
the physiological ROM. Similar to all nucleus replacement devices and unlike a total disc 
replacement, the device ranges of motion are largely dependent upon the constraints from 
the adjacent tissues, and is designed to restore or maintain the load sharing capabilities of 
the index disc.  
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Fig. 6. PEEK nucleus replacement device. 
2.2.1 Axial static and fatigue strength 
To determine the static and fatigue strength of the device, the smallest footprint (11x20 mm) 
and height (8 mm) was utilized. These were considered the worst-case scenario for contact 
stress distribution. The specimens tested were representative of the smallest true contact 
stress area for all current designs. Testing was performed on an MTS 858 Mini-Bionix II test 
frame with steel fixturing. A sample size of 3 was used for the static tests with a 
displacement rate of 2 mm/min. The acceptance criteria was an offset yield load of greater 
than 2200 N (Lowe, 2004) for the axial static testing. For the fatigue tests, a sample size of 6 
was used with a runout load criteria of 3000 N to 5 million cycles (FDA guidance), with 
R=10 at 10 Hz. 
The results of the axial static testing showed that the mean offset yield was 10868 ± 413 N. 
The primary failure mode was excessive plastic deformation of the top component of the 
device. For the axial fatigue test, two specimens were tested at a peak compressive load of 
9238 N with both failing within 200 cycles due to excessive plastic deformation of the top 
component, similar to the axial static testing. Two other specimens ran out to 10 million 
cycles at a peak compressive load of 8151 N. However, upon visual inspection, fatigue 
cracks emanating from the radiographic marker hole were discovered. Therefore, the load 
was dropped down to 7065 N for an addition two samples, with a successful outcome. This 
represented 85%, 75% and 65% of the mean offset yield compressive load, respectively. 
These results are thought to be well beyond those of the expected in vivo physiological loads, 
and therefore failure was not expected to occur in either static axial compression or dynmaic 
axial compression. 
2.2.2 Shear fatigue strength 
To determine the static and fatigue strength of the device, the smallest footprint (11x20 mm) 
and height (8 mm) was utilized. The specimens tested were also representative of the 
smallest true contact stress area for all current designs. Testing was performed on an MTS 
858 Mini-Bionix II test frame with steel fixturing. A shear angle of 15° was selected based 
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upon a review of the relevant literature. Extreme flexion of the lumbar spine appears to be 
approximately 10° on average, with slightly more at the levels L2L3 to L4L5 and slightly less 
at L1L2 and L5S1 when measured in vivo (Pearcy, 1984). Therefore, a 15° angle was 
considered to be at the physiological extreme. Two specimens were used to characterize the 
shear fatigue strength of the device. 
Given the compressive loads obtained during the axial testing, only shear fatigue testing 
was performed. The two test specimens were successfully tested to 10 million cycles at 6600 
N. There is limited data on flexion fatigue testing of human cadaveric lumbar motion 
segments. The available data states that fatigue failure can occur on average at 263 ±646 
cycles with 9 kg of cyclic loading (representing a peak load of 3150 N) at 6° of flexion 
(Gallagher, 2005). It was therefore thought that the device has adequate compressive-shear 
fatigue strength for its intended application. 
2.2.3 Wear testing and wear particulate characterization 
All implants used for wear testing were applicable to a clinical setting and were of the 
smallest height (8 mm) and footprint (11x20 mm) available. Three separate groups of six 
implants each were utilized in this wear study. Table 2 summarizes the test methodology. 
The peak compressive load of 1024 N was chosen based upon the physiological load sharing 
expected of nucleus replacement devices. The peak compressive load of 2000 N represents a 
worst case scenario in the event that the device must support the entire compressive load on 
the anterior column. Group 2 was exposed to 200 kGy of gamma radiation followed by 
simulated aging. The simulated aging process was similar to ASTM F2003-02, which was 
developed to measure accelerated aging of UHMWPE in air at 70° C and 5 atm of oxygen, 
except that the aging time was extended from 14 days to 40 days. All implants were pre-
soaked in test fluid for at least 6 weeks. All groups were tested on a six-station spine wear 
simulator (EndoLab GmbH). The testing fluid consisted of newborn calf serum  diluted with 
phosphate buffered saline (PBS) to a final protein content of 20 g/L. Ethylene-diamine 
tetraacetic acid (EDTA) was added to the serum at a concentration of 20 mM to bind the 
calcium ions present in the serum. EDTA is a known preservative, and together with the low 
protein content and PBS, the addition of sodium azide or other anti-bacterial agent was not 
used. The test fluid temperature was kept at 37 ± 3° C. Although not part of the test 
methodology, group 2 was temporarily stopped at 5 million cycles due to simulator 
availability whereupon the implants were immersed in saline at 37 ± 3° C for 33 weeks. 
Although unintended, this represented an additional test parameter. The test was 
subsequently resumed until 10 million cycles was reached. Unloaded soak controls were 
used for all groups to account for moisture uptake. Group 3 was tested at approximately 
double the compressive load. The tests were stopped at half million-cycle intervals to clean, 
dry and gravimetrically assess the wear rates. The average wear rates were determined 
using linear regression analysis with one-way-analysis-of-variance (ANOVA) used to 
determine if significant differences (p < 0.05) in the wear rates was present. The 
proteinacious test serum containing PEEK wear debris underwent enzymatic digestion (5x 
Trypsin digestion and 1.5 mg/mL of Proteinase K per sample at 37° C for 24 hours) 
followed by a mild acid treatment (10% HCl at 37° C for 24 hours), meeting or exceeding 
similar protocols previously established to be equivalent for acid and base digestion 
(Niedzwiecki, 2001). The particles were then analyzed by SEM analysis and characterized 
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according to their equivalent circle diameter (ECD), aspect ration (AR), roundness (R) and 
form factor (FF) in accordance with ASTM F 1877-05. 
All implants for each group maintained full functionality throughout each test duration 
with visual and light microscopy revealing no evidence of gross deformation, delamination 
or fatigue cracks. Since group 1 desplayed a wear-in period from 0-1.0 million cycle, the 
wear rates were calculated from 1 million cycles on for all groups. For group 1, the wear rate 
was calculated to be 0.41 ± 0.01 mm3/million cycles. For group 2, the wear rate was 
calculated to be 0.52 ± 0.02mm3/million cycles. For group 3, the wear rate was calculated to 
be 0.92 ± 0.01 mm3/million cycles, which was significantly higher than groups 1 and 2. This 
increase in the wear rate was to be expected, given that the peak compressive load was 
increased from 1024 N to 2000 N. Overall, the wear rates are less than contempary lumbar 
total disc arthroplasty devices, which can range from 2.8 to 20.4 mm3/million cycles 
(Bushelow, 2007; Nechtow, 2006; Grupp, 2009) (Figure 7). The particle analysis conducted 
via SEM revealed that group 1 had the smallest particulate of 1.09 µm, followed by groups 2 
and 3 at 1.71 µm and 1.86 µm respectively. Other than the aspect ratio for group 1, the 
morphology of the wear particulate appears to be similar for all the groups tested (Figure 8). 
Using standard nomenclature for describing particle morphology in accordance with ASTM 
F1877-05, the larger particulate tended to be mostly somewhat roughened or smooth flakes, 
with some shards and globular particles, along with a few fibrils. Any submicron particulate 
was smooth, with spheroidal granules.  
 
 
 
 
 
Fig. 7. Average wear rates for the PEEK nucleus replacement device. 
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Fig. 8. SEM analysis of the PEEK particulate generated from the wear tests. 
2.2.4 Biomechanical analyses 
The first study sought to assess the restoration of disc height, the potential adverse effects of 
the device on the underlying vertebral endplate under physiological loading conditions and 
an initial assessment of the extrusion risk. A total of eight fresh-frozen human lumbar 
functional spinal units (L2L3 and L4L5) were harvested en-bloc and utilized in this 
investigation. Prior to biomechanical analysis, standard anterior/posterior and standard 
lateral plain films were obtained to exclude specimens demonstrating intervertebral disc or 
osseous pathology. Bone mineral density (BMD) scans (DEXA) were performed to exclude 
specimens demonstrating BMD’s less than 0.9 g/cm3. Each test specimen consisted of two 
contiguous functional spinal units (three vertebra and two intervertebral discs). One 
intervertebral disc served as a control and the other intervertebral disc was implanted with 
the device. To determine restoration of disc height, a 1200 N compressive load was applied. 
An annular incision followed by a box cut (6 mm x 10 mm) was created on the anatomic 
right, followed by a complete nucleotomy. A fatigue test was conducted under a left lateral 
bending moment ranging from 2.5 to 7.5 Nm (250 to 750 N compressive load offset 10 mm). 
The test was run at 2 Hz for 100,000 cycles. The left lateral bending mode represented a 
“worst case” scenario with regards to implant extrusion. Upon completion of the 
biomechanical analyses, each specimen was radiographed and examined for possible 
fractures and/or migration. Segments were then dissected transversely through the 
intervertebral discs. Both the intact and implanted discs were examined macroscopically for 
potential changes. Photographs of the disc were taken using a macro lens to document the 
condition of the endplates and the annulus. The L1 and L4 vertebrae were scanned on a 
mCT 80 (ScancoMedical AG, Bassersdorf, Switzerland) to examine the trabecular bone for 
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potential fractures. The specimens were scanned with an x-ray energy of 70Kvp and current 
of 114 mA and at an isotropic voxel resolution of 74 microns (image matrix of 1024 x 1024). 
A total of 500 projections over 180 degrees were collected for each vertebra. An integration 
time of 700 ms/projection was used, which resulted in a scan-time of about 2.5 - 3 
hours/specimen. A repeated measures ANOVA was used to examine differences in ROM 
between intact, discectomy, and implant conditions. Implant extrusion was assessed by 
direct observation made from the pre and post fatigue radiographs. Gross macroscopic 
fractures were determined from the dissection and radiographs for both the control and 
surgical levels. The microCT images were analyzed by a board certified radiologist (Medical 
Metrics, Inc. Houston, Texas, USA). The disc height of 2.2 ± 0.6 mm after discectomy 
significantly decreased (p<0.05) to 3.7 ± 1.1 mm for all specimens in comparison to the intact 
condition under 1.2 kN of compressive loading. Implantation of the nucleus device 
significantly increased (p<0.05) the disc height to 2.6 ± 0.7 mm compared to the discectomy 
condition. There was no significant difference between the intact and implanted conditions. 
There were no gross endplate fractures observed at the completion of 100,000 cycles of 
lateral bending. The evaluation of the microCT images noted no fractures in the endplates or 
vertebral bodies. There were slight migrations of the device towards the annulotomy, but no 
extrusions noted. 
The second study performed was to quantify the ROM and destructive load to failure 
properties of the device. A total of eight fresh-frozen human lumbar functional spinal units 
(L2L3 and L4L5) were harvested en-bloc and utilized in this investigation. Prior to 
biomechanical analysis, standard anterior/posterior and lateral plain films were obtained to 
exclude specimens demonstrating intervertebral disc or osseous pathology. BMD scans 
using DEXA were performed to exclude specimens demonstrating BMD’s less than 0.9 
g/cm3. To determine the multidirectional flexibility, six applied pure moments of  7 Nm 
(flexion and extension, left and right lateral bending, and left and right torsion) were 
applied to the superior end of the vertically oriented specimen while the caudal portion of 
the specimen remained fixed to a testing platform. Following the intact analysis, an annular 
incision followed by a box cut (10 mm x 10 mm) was created on the anatomic left, followed 
by a complete nucleotomy. After biomechanical testing of the destabilized condition, the 
nucleus device was implanted and the operative motion segment retested. As a final test, the 
reconstructed specimen was destructively evaluated under axial compression. 
Biomechanical data was normalized to the intact condition and expressed as mean ± one 
standard deviation, with a Repeated Measures Analysis of Variance (ANOVA) and Student-
Newman-Keuls test to determine differences among individual groups (p<0.05).  
Multidirectional flexibility testing indicated significant increases in the segmental range of 
motion and neutral zone secondary to the annulotomy/nucleotomy procedures after 
reconstruction of the operative segment. For both calculated parameters, the segmental 
rotation increased for the destabilized condition versus the intact and reconstructed 
specimens (p<0.05). Importantly, the neutral zone, an indicator of spinal stability of the 
reconstructed segment, returned to levels not statistically different from the intact condition. 
As a final test, the reconstructed specimens were destructively evaluated under axial 
compression. In all specimens except one, the observed failure mechanism was fracture of 
the vertebral body, without significant disruption of the vertebral endplate. The primary 
mode of fracture was through the vertebral bodies above and below the operative disc level. 
The mean failure load was 3340 ± 2029 N. This average fracture load is comparable to the 
compressive failure load for intact lumbar segment (Lowe, 2004). 
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2.2.5 Functional animal study 
Evaluation of the mechanical behavior and elicited histopathological response following 
long-term implantation in a functional animal (baboon) model of the device was performed. 
Fourteen mature male baboons (Papio cynocephalus) were randomized into two post-
operative time periods of six-months (n=7) and twelve-months (n=7). Each animal 
underwent a lateral transperitoneal surgical approach followed by complete nucleotomy at 
L3-L4 and L5-L6 levels. The inferior L5-L6 level was reconstructed using the nucleus 
replacement device while the adjacent level served as a control. 
Analyses were based on gross necropsy, MRI radiography, plain X-ray, microradiography, 
and biocompatibility assays (local and systemic histology) performed at the six and twelve 
month post-operative time-points. resected, sectioned and prepared by a veterinarian 
pathologist. The specimens were fixed in a 10% formalin solution, underwent routine 
paraffin processing and slide mounting. Using thin-sectioning microtomy, the paraffin 
embedded sections were cut (3-5μm in thickness), slide mounted and stained using standard 
Hematoxylin and Eosin (H&E). The spinal cord sections, obtained from each operative disc 
level, were evaluated using routine H&E. The local tissues overlying the operative levels 
underwent the following immunocytochemistry analyses using standard 
immunocytochemistry techniques, including primary and secondary antibodies combined 
with the avidin-biotin complex (ABC)-horseradish peroxidase. Immunohistochemical 
localization of intracellular and membrane bound macrophage expressing cytokines 
included IL-1, IL-2, IL-6 and Tumor Necrosis Factor-Alpha and beta (TNF-ǂ,ǃ). The 
Macrophage Staining Method (HAM-56) was used to highlight the presence of activated 
macrophages within the local tissues. Using plain and polarized light microscopy, 
histopathological readings of the slide-mounted tissues, activated macrophages, presence of 
wear debris as well as any signs of foreign body giant cells, granulomas inflammatory 
reactions, degenerative changes or autolysis could be discerned. Pathological assessment for 
all systemic and local tissues included, but was not limited to, the architecture of the tissues, 
presence of wear debris as well as any signs of foreign body giant cell / granulomas 
inflammatory reactions, degenerative changes or autolysis.  
Multidirectional flexibility testing indicated no difference in axial rotation (p>0.05) for the 
six-month groups, comparing the intact spine to surgical motion segments. 
Flexion/extension and lateral bending exhibited reduced segmental motion for the nucleus 
replacement device and operative control levels at six months versus the non-operative 
intact spine (p<0.05). However, these findings were also noted in the operative control levels 
demonstrating the effect of surgical intervention itself on segmental stability. At twelve 
months, segmental motion was restored to the intact levels for the reconstructed levels 
(p>0.05). Histopathologic analysis of the nucleus replacement treatment exhibited increased 
densification of trabeculae along the endplate periphery, which corroborated with Modic 
Type I changes observed with MRI and radiographically. Evidence of implant subsidence 
was noted in 5/7 cases at six months and 7/7 cases at twelve months, which correlated with 
the absence of articular cartilage in some regions. A limitation of this study was the use of a 
single height nucleus replacement device for all treated discs. This resulted in difficulties in 
insertion and placement of the device and significant over distraction of the disc space. The 
difficulties in insertion and over distraction may have resulted in the use of more force for 
proper placement. This potentially induced endplate damage at the treated disc levels and 
led to abnormal high contact stress on the endplates, which may have been the precursor to 
the Modic changes and subsidence. Plain and polarized light microscopy of local tissues 
overlying the operative sites from both the experimental and control levels indicated a 
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chronic inflammatory reaction, with evidence of fibrous connective replacement and 
infiltration of mononuclear cells. These observations were considered secondary to the 
surgical procedure and, importantly, occurred at both the control and experimental 
operative levels. There was no evidence of cellular apoptosis, giant cell reaction or other 
significant pathological changes. Analysis of the immunohistochemical antibody stains for 
the local tissues overlying the experimental and control levels were negative in each case. In 
the histological analyses, there was no detectable wear debris from the device and no 
evidence of an osteolytic response. There was no evidence of a pro-inflammatory cytokine 
reaction at any of the experimental or control levels.  
3. Clinical summary 
Worldwide clinical usage of both devices is ongoing. Currently, there have been no reported 
adverse events due to a material failure, such as device breakage, fatigue failure or an 
aggressive host immune response leading to a revision surgery to remove the device. 
Clinical results as measured by validated measures such as Oswestry Disability Index (ODI) 
and Visual Analog Scale (VAS), along with patient satisfaction, suggest that both devices 
can relieve the symptoms of their respective degenerative processes (Figures 9, 10). From a 
biomaterial perspective, no adverse events have occurred as a direct result of these devices  
not performing as expected. Based upon worldwide clinical success, and the success of a US 
pilot IDE study, the nucleus replacement device was granted approval by FDA to start a 
first of its kind IDE pivotal study in the US. 
 
 
Fig. 9. ODI and VAS scores from the worldwide usage of the cervical arthroplasty device. 
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Fig. 10. ODI and VAS scores from the US IDE pilot study for the nucleus replacement 
device. 
4. Conclusion  
The concept of reconstruction of the lumbar and cervical disc is not new, as clinical 
experimentation goes back to the early 1950’s. Since then, the scientific and clinical 
community has sought to improve upon the selection of available biomaterials for use in the 
disc arthroplasty arenas. The mainstay of these materials has been ceramics, metal alloys 
and polymers, in large part due to the history gained form their use in total joint 
reconstruction. Currently there is no universal material that is considered the ultimate 
biomaterial, and an in-depth knowledge of a given material is important in understanding 
and predicting its response when used in an application as demanding as an implantable 
biomaterial. Knowledge can be gained by not only performing the appropriate testing on 
the bulk properties of the material, but also proper preclinical testing of the constructed 
device. More importantly, adroit interpretation of these results is fundamental to the clinical 
success of the device (Fraser, 2004; Kurtz, 2009). The use of PEEK in spinal arthroplasty 
represents a new application of this material. Although the history of PEEK suggests that it 
has the necessary material properties to serve as a long-term implantable arthroplasty 
material, it’s use in the form of any arthroplasty device has not been diligently explored. 
Therefore, a battery of preclinical testing was performed, and the interpretation of the 
results for both a cervical disc arthroplasty device and lumbar nucleus replacement device 
have allowed for successful advancement to the clinical usage. The results of these 
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combined preclinical studies described can be used in an ongoing basis to further analyze 
the use of PEEK in arthroplasty applications. Long term clinical follow up is needed to 
further support the preclinical results.  
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